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Dr John D. Mitchell, MD (Denver, Colo). The ACOSOG Z30
studywas a randomizedmulti-institutional prospective trial designed
to assess the relative merits of mediastinal lymph node dissection
versus sampling in patients with early-stage lung cancer, both in
terms of the perioperative morbidity of the 2 procedures and the
long-term oncologic outcomes. Thefirst has been reported, asWalter
said, and we await the data regarding recurrence and survival.
This current study examines a subset of the Z30 patients who un-
derwent a lobectomy, bilobectomy, or segmentectomy. Through
the magic of propensity scoring, these patients have been distilled
down into 2 matched groups: 66 patients who underwent anatomicThe Journal of Thoracic and Calung resection via a thoracoscopic approach and 686 patients who
had an open procedure. The VATS group had shorter operative
times, less chest tube drainage, shorter chest tube duration, shorter
hospitals stays, less respiratory problems requiring intervention,
and less complications overall. I was gratified to see that your find-
ings matched my own personal observations about VATS proce-
dures, but I have a couple questions for you.
First, the majority of the VATS procedures, 82%, were done by
1 surgeon. How do we really know that the differences that you are
reporting today are related to the 2 different surgical approaches?
An alternative possibility is that these results just reflect practice
differences between the surgeon and the rest of the ACOSOG par-
ticipants. For example, if the VATS surgeon in question is more lib-
eral with chest tube removal, with less regard for the output, the
chest tube duration is going to be shorter, and the hospital stay
will probably be shorter.
Dr Scott. That is the key confounder in this analysis, as I men-
tioned. The protocol did not mandate how chest tubes were man-
aged. Therefore, a surgeon’s practice pattern, for example, his/her
willingness to remove a chest tube that drained 400 mL in the pre-
vious 24 hours compared with waiting for drainage to decrease to
250 mL in the previous 24 hours, would make a difference in the
timing of chest tube removal. End points such as chest tube removal
have to be looked at with that in mind. However, regarding other
end points such as mortality, lymph node dissection, and so on, I
believe the study shows that VATS lobectomy can be done and
achieve similar results to open lobectomy. Those end points are
perhaps less affected by the fact that 1 surgeon did most of the pro-
cedures in the VATS group. The study demonstrates that VATS
lobectomy can achieve those similar goals.
Dr Mitchell. Second, there were 10 times as many patients in
the open resection group compared with the VATS group. There
were other differences as well, such as in the performance status.
Do you have any concerns about the validity of your results based
on these discrepancies between the 2 groups given the statistical
methods and scoring variables used?
Dr Scott. I think propensity matching is probably one of the
most sophisticated methods we have for performing a nonrandom-
ized comparison such as we did here. The alternative is to do some-
thing called case matching where you find 66 patients in the open
resection group who are similar to the 66 patients in the VATS
lobectomy group. Problems with the case-matching approach in-
clude accurately identifying similar patients from each group (ie,
how does one determine how similar is similar enough?) and the
fact that a significant number of patients would be excluded from
the analysis. This can actually increase the amount of bias in the
analysis. The fact that one has a large control group is actually
favorable for this type of statistical analysis.
Dr Mitchell. Finally, a VATS approach was used selectively in
the Z30 trial at the discretion of the operating surgeon. Could you
comment onhow this factmight have affected the results inyour trial?
Dr Scott. I hope that the differences we saw in baseline charac-
teristics were corrected by the propensity matching, and therefore
the patients were as similar as possible. That gets at the heart of
doing this kind of nonrandomized comparison. The choice by
a given surgeon of whether to offer a VATS or open procedure
should be accounted for by the statistical method because both
groups of patients should be similar.rdiovascular Surgery c Volume 139, Number 4 981
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SDr Robert Cerfolio, MD (Birmingham, Ala). Walter, this is an
interesting article. However, I come to meeting after meeting and
listen, and I keep hearing that VATS is better, and I keep waiting
for some data to convince me, and, once again, no offense, but
this is not it.
Did you compare DrMcKenna’s open cases with DrMcKenna’s
VATS cases? Because that is really what the article was. In other
words, did you look at the time frame for Rob’s open thoracotomies
and were the chest tubes removed as quickly as in the VATS cases?
I know we do at UAB, and we do some, although not many VATS
lobectomies. To me, that would be the only important data and
analysis from this study.
Finally, because I continue to hear this meeting after meeting, I
am performing VATS lobectomy now, even some robotic work,
and I see no difference in chest tube management. Perhaps I am
just a much worse VATS surgeon than you guys or maybe you
guys just don’t do your thoracotomies the way I do: spare the rib,
most of the muscle, and all the intercostal nerves. Maybe you do
not fast track these patients or have the mindset that their tubes
can come out after 1 or 2 days and they can go home after 3 days
and return to full activities after 3 or 4 weeks. I think if you just
treated the open cases more like the VATS cases you might not
see a difference. Can you comment on that?
Dr Scott. Those are 2 interesting points. I don’t think these data
settle the question, and perhaps a randomized trial is necessary, but
I am not sure there is equipoise in the general thoracic surgery com-
munity to do such a trial.
Dr McKenna did not have many patients who underwent the
open procedure to compare; therefore, the type 2 error would
probably be great, so we could not do that. We did perform an
exploratory analysis looking at centers that performed VATS lo-
bectomy compared with centers that performed open lobectomy,
and there was a trend for a shorter length of stay with open cases
as well in centers that performed VATS lobectomy as opposed to
those centers that performed only open resections. Some people
might see that as a criticism therefore or a reason to think that
VATS is not as good; I would argue the opposite, that the expe-
rience with VATS lobectomy led the surgeons to fast track their
open resections, if you will, and that there is something about the
experience of doing VATS lobectomies that benefits all the pa-
tients.
Dr Cerfolio.Okay, my only point is I would just be careful with
your conclusions given the methodology of this study.
Dr David Follette, MD (Sacramento, Calif). Dr Scott, this was
a superbly presented article. I do, however, share Dr Cerfolio’s con-
cerns. We now know that VATS lobectomy can be done safely by
experienced VATS surgeons. We also know there may be some
short-term advantages. It is not known if these apparent advantages
will really make any long-term difference.
I too share concerns about your data where the majority of cases
were done by a single surgeon who is recognized as the world’s au-
thority and has the largest experience. We are all aware of Dr
McKenna’s published results, and they certainly set a lofty standard
for all surgeons who choose this approach. If there were a broad-
based series, would the results for VATS lobectomy be compara-
ble?
Thus, I have grave concerns that essentially a single-surgeon se-
ries be compared with a group of other surgeons doing open lobec-982 The Journal of Thoracic and Cardiovascular Surgtomies. I don’t believe your subset analysis is statistically valid.
Could you please comment on this?
Dr Scott. There are always concerns when one does post hoc or
subset analyses such as this. Basically I would say that the data are
what they are. They have been analyzed in an excellent fashion by
the ACOSOG statisticians, and these are the conclusions we can
come to. As I mentioned, they need to be interpreted in light of
the fact that 1 surgeon did most of the VATS procedures.
Dr Follette. Don’t you think this is a lot like all the published
and presented studies on off-pump versus on-pump coronary by-
pass surgery? Do you believe that we should answer the question
as to open versus VATS lobectomy in a similar manner that an-
swered the off versus on-pump surgery question? As you may re-
call, Emory University conducted a statistically relevant study
that randomly assigned patients to either technique. All procedures
were done by a single cardiac surgeon with extensive experience
with both techniques. As you may recall, when the data were ana-
lyzed, there was no statistical difference in outcomes or complica-
tions between these 2 techniques. Do you think that if a high-
volume center, with extensive experience with both techniques,
would be willing to do such a study that this would answer the ques-
tion once and for all?
Dr Scott. I think that would be a good idea, and I leave it up to
those centers to take on that task.
Dr Douglas Wood, MD (Seattle, Wash). Walter, nicely pre-
sented. But, I have to take the previous criticisms and perhaps em-
phasize them even greater.
It’s not legitimate to title the article the way it is titled. This is not
really a comparison of VATS versus open. This is a comparison of
RobMcKenna versus the rest of the thoracic surgeons in the United
States. I mean you could title the article as that, ‘‘Preoperative Out-
comes of Resection for Lung Cancer: A Comparison of Dr
McKenna and the Rest of the US Thoracic Surgeons.’’ It would
be an equally legitimate title and a data analysis, albeit not as inter-
esting or provocative as a title comparing VATS with open. I ques-
tion whether this is really something that we should put in the
literature because of that. This problem of confounding, of Rob
McKenna doing 82% of the VATS cases, it just can’t be overcome
statistically.
I challenge your statement that there is not equipoise in the tho-
racic surgery community to achieve this as a randomized trial. Dr
Mitchell and I can have completely different opinions about the
validity of VATS lobectomy. He can think that VATS is abso-
lutely better, and I can be cynical and not sure about that, just
like Dr Cerfolio. That is equipoise in the thoracic surgery commu-
nity. Maybe we don’t have it individually, but we don’t have to as
long as I respect John Mitchell’s point of view and he respects my
point of view; we actually have the capability of conducting a ran-
domized trial because we recognize that it is an unanswered ques-
tion. I request that we as thoracic surgeons get off of our position
that this has already been defined, because it has not, and through
ACOSOG or other sources put forward a randomized trial and
work together.
Dr Scott. In response to your initial comments, I would point out
the strengths of this study: the standardized definitions of compli-
cations and outcomes, the prospective data collection, and the care-
fully audited data (unlike many national databases). Useful
conclusions can be drawn from these data.ery c April 2010
Scott et al General Thoracic SurgeryRegarding your second point, at meetings such as the gen-
eral thoracic surgery club, whenever someone asks for a show
of hands of those willing to participate in a randomized study
of VATS versus open lobectomy, nobody raises his or her
hand. That demonstrates a lack of equipoise in the thoracicThe Journal of Thoracic and Casurgery community in that you may think open is better, I
may think VATS is better, and I’m not willing to randomize
my patients. Unless these attitudes change, there does not cur-
rently seem to be much likelihood of a randomized trial
succeeding.rdiovascular Surgery c Volume 139, Number 4 983
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